ImpediMed Ltd
ASX:IPD

Watchlist Manager
ImpediMed Ltd Logo
ImpediMed Ltd
ASX:IPD
Watchlist
Price: 0.034 AUD 3.03% Market Closed
Market Cap: 68.9m AUD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+24%
Revenue
Forecast
+7%
Operating Income
Forecast
+33%
Net Income
Forecast
+30%

Wall Street
Price Targets

IPD Price Targets Summary
ImpediMed Ltd

Wall Street analysts forecast IPD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IPD is 0.138 AUD with a low forecast of 0.091 AUD and a high forecast of 0.179 AUD.

IPD Lowest Forecast
Wall Street Target
0.091 AUD
167% Upside
IPD Average Forecast
Wall Street Target
0.138 AUD
305% Upside
IPD Highest Forecast
Wall Street Target
0.179 AUD
425% Upside
Lowest
Price Target
0.091 AUD
167% Upside
Average
Price Target
0.138 AUD
305% Upside
Highest
Price Target
0.179 AUD
425% Upside
ImpediMed Ltd Competitors:
Price Targets
1302
LifeTech Scientific Corp
25% Upside
MOVE
Medacta Group SA
21% Upside
IRTC
iRhythm Technologies Inc
29% Upside
SEDANA
Sedana Medical AB (publ)
128% Upside
1302
LifeTech Scientific Corp
25% Upside
MOVE
Medacta Group SA
21% Upside
IRTC
iRhythm Technologies Inc
29% Upside
SEDANA
Sedana Medical AB (publ)
128% Upside
DXCM
Dexcom Inc
47% Upside
M
179290
MITech Co Ltd
63% Upside
LMAT
LeMaitre Vascular Inc
18% Upside
RMD
Resmed Inc
16% Upside

Revenue
Forecast

Revenue Estimate
ImpediMed Ltd

For the last 8 years the compound annual growth rate for ImpediMed Ltd's revenue is 7%. The projected CAGR for the next 3 years is 63%.

7%
Past Growth
63%
Estimated Growth
Estimates Accuracy
-15%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
ImpediMed Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-2%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
ImpediMed Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-69%
Average Miss
What are analyst estimates?

See Also

Summary
IPD intrinsic value, competitors valuation, and company profile.
DCF Valuation
IPD stock valuation using Discount Cash Flow valuation method.
Relative Valuation
IPD stock valuation using valuation multiples.
Wall Street Estimates
IPD price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
IPD stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IPD's stock price target?
Price Target
0.138 AUD

According to Wall Street analysts, the average 1-year price target for IPD is 0.138 AUD with a low forecast of 0.091 AUD and a high forecast of 0.179 AUD.

What is ImpediMed Ltd's Revenue forecast?
Projected CAGR
63%

For the last 8 years the compound annual growth rate for ImpediMed Ltd's revenue is 7%. The projected CAGR for the next 3 years is 63%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 248,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.